Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 4Interventional 2

Sponsor

Cancer Type

Gastrointestinal 27Genitourinary 16Thoracic 14Gynecologic 14Other hematologic neoplasm 13Lymphoid 11Head & Neck 10Breast 10CNS 9Dermatologic 7Plasma cell 5Tumor-Agnostic 3Myeloid 3Sarcoma 2Other solid neoplasm 2Endocrine 2Classical hematology 2Other neoplasm 1Other 1

Conditions

Osteoporosis 1Obesity 1Hypertension 1Hypercholesterolemia 1Diabetes Mellitus 1Cushing Syndrome 1Adrenocortical Carcinoma 1Adrenal incidentaloma 1Adrenal Gland Neoplasms 1

Interventions

Everolimus 59lutetium Lu 177 dotatate 46Magnetic Resonance Spectroscopy 33pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 24lanreotide 23cabozantinib 22pasireotide 21gallium Ga 68 dotatate 21lenvatinib 20Etoposide 19Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18Sunitinib 17Bevacizumab 16trametinib 15dabrafenib 15Doxorubicin 143-Iodobenzylguanidine 14surufatinib 13Sorafenib 13Ipilimumab 13Thyrotropin Alfa 12Injections 12Positron Emission Tomography Computed Tomography 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Observation × Endocrine × Clear all
NCT03723941 2024-08-01

ACACIA

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 3 Completed
40 enrolled
Endocrine

Adrenocortical Carcinoma

NCT02001051 2018-06-14

Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
4 enrolled 10 charts
EndocrineOther

Adrenal incidentaloma, Adrenal Gland Neoplasms, Cushing Syndrome, Diabetes Mellitus, Hypercholesterolemia, Hypertension, Obesity, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡